Podcasts about africa cdc

Kyeng Mercy and Nuria Clemente Sanchez take us through the continental response to mpox, the Africa CDC data on mpox in children younger than 15 years, and African priorities in response to the mpox public health emergency.

Mpox continues to spread in Africa and young children are experiencing the highest mpox burden and mortality of all ages. In this episode Kyeng Mercy, epidemiologist at Africa Centres for Disease Control and Prevention takes us through the continental response to mpox, the Africa CDC data on mpox in children younger than 15 years, and African priorities in response to the mpox public health emergency. Alongside her, Nuria Clemente Sanchez, paediatric infectious disease specialist at City St George's, University of London shares what paediatricians and clinicians need to know about how mpox presents and the latest information on mpox vaccine and therapeutic trials.Mpox among children in Africa https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(25)00064-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanchiHidden in plain sight: the threat of mpox to children and adolescents https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(24)00298-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanchiPaediatric, maternal, and congenital mpox: a systematic review and meta-analysis https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(23)00607-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanchiContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://www.linkedin.com/company/lanchi/https://youtube.com/thelancettv

Vaccinations play an important role in both our individual and community health. They help to prevent serious and sometimes deadly diseases by strengthening our immune system. But in recent years this cost effective method of disease prevention has come under the spot light, drawing attention to some myths and misconceptions. In this episode, Dr Anne von Gottberg dives into the importance of vaccinations, how to handle missed vaccines, vaccine dos and don'ts and recent changes in the Extended Programme onIimmunzation(EPI) in South Africa.About our Guest: Dr Anne von Gottberg is currently the laboratory lead at the Centre for Respiratory Diseases and Meningitis at the National Institute for Communicable Diseases, Johannesburg, South Africa; and Associate Professor within the School of Pathology, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg; and Honorary Professor, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town. She leads a laboratory team responsible for reference diagnostics for respiratory and meningitis pathogens nationally and regionally. The laboratory is the regional reference laboratory for the World Health Organization (WHO) Vaccine-preventable Invasive Bacterial Diseases (VP-IBD) Coordinated Global Surveillance Network for the southern African region; a National Influenza Centre (NIC); and a global WHO RSV and regional SARS-CoV-2 reference laboratory. She is currently a member of several committees and technical advisory groups for AFRO, Africa CDC and WHO. Her main interests include surveillance for meningitis and respiratory pathogens, assessing vaccine effectiveness where relevant. She has authored or co-authored more than 200 articles in peer-reviewed journals. In addition, she supervises a number of Masters and PhD students. Dr von Gottberg obtained her MBBCh and PhD at the University of the Witwatersrand, and trained for her specialisation in clinical microbiology (FC Path[SA] MICRO) at the National Health Laboratory Service (former South African Institute for Medical Research) and at the University of the Witwatersrand.WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: mail.microbe@gmail.com

Africa's Center for Disease Control and Prevention – Africa CDC – says it is battling to identify a new disease in the Democratic Republic of Congo that has claimed at least 79 lives and infected hundreds more. Columbus Mavhunga reports from Zimbabwe's capital, where the Southern African Association of Doctors for Human Rights is calling for a regional approach to stop the disease from spreading to other countries

Send us a textSmallpox may be gone but it's got a cousin called mpox, and that virus is now spreading fast across parts of Africa.As of October 2024, this mpox outbreak had infected more than 40,000 people, mostly in the Democratic Republic of Congo, according to the Africa Centres for Disease Control and Prevention. More than 1,000 people have died from the infection. The World Health Organization (WHO) declared mpox in the Democratic Republic of Congo and neighboring countries to be a Public Health Emergency of International Concern in August 2024.Officials are distributing smallpox vaccines to try to control it. The viruses are closely enough related so researchers believe that modern smallpox vaccines can protect people safely against mpox. But the rollout is slow.  It's not clear why the virus has started spreading in households, but it's infecting and killing more and more children.To make matters worse, people are desperate for medicines to prevent infection and help treat symptoms, which include fevers and a rash. They're seeking antibiotics, which cannot treat a virus. This inappropriate use of antibiotics can drive drug resistance.This is the second time mpox has been declared a public health emergency by the WHO since 2022. A slightly different strain of mpox has been spreading since then through close contact, often sexual and often among men who have sex with men. Mpox is even now showing up in new cities and countries in North America and Europe.Nodar Kipshidze, Senior Research Analyst at the One Health Trust, says the virus spreads easily because people often don't know they have it. It's also not clear where it originally came from, although small rodents and other mammals can spread it. In this episode of One World, One Health, Nodar tells us mpox is causing a lot of confusion, and we need to ensure we learn from previous outbreaks and share resources globally to stop the spread and save lives.

A new study from America looks at the safety of organ transplants between people with HIV. Its promising results raise the potential for expanding access to life-saving treatments.This week's show also examines a surprising resurgence of scurvy, a disease often associated with historical poverty. Is the current cost of living crisis contributing to nutritional deficiencies? Plus, an update from the Africa CDC reveals encouraging news about the Marburg virus outbreak, but a grim warning about the spread of Mpox. Presenter: Claudia Hammond Producer: Margaret Sessa Hawkins

Nidhi Bouri, DAA at USAID Bureau for Global Health, joined us to speak to the U.S. response to the dangerous mpox outbreak (clade 1b) centered in the Democratic Republic of Congo, boosted by President Biden's commitment at UNGA to $500m in support, including 1 million vaccine doses. Much better data is urgently needed on the needs for diagnostics and vaccines. Tensions remain high among Africa CDC, WHO, and other key institutions with proven response capability, most notably Gavi, UNICEF and the Global Fund. Much is not known about modes of transmission, and the durability and efficacy of the Jynneos vaccine for clade 1b. As the virus inevitably lands in the United States, communications will be critical. Some important progress was seen in the High Level Meeting on anti-microbial resistance. The Marburg outbreak in Rwanda is of acute concern for multiple reasons: no vaccine, little testing, little knowledge of the pattern of spread. It is crunch time, as multiple replenishments converge. “Let's be clear, there is not enough money.”

On Daybreak Africa: Head of the African Union's health watchdog said it was time for the West to show it had learned from the Covid pandemic and not abandon Africa during the mpox outbreak. Plus, the US proposes two new permanent seats on the UN Security Council for Africa. A new report says if the Islamic State Somalia branch has become a financial hub, its leader may become overall chief of the IS. Kenyan President William Ruto visits Germany. Senegalese President Bassirou Diomaye Faye dissolves the National Assembly and calls for new legislative elections on November 17. As the gender gap among voters widens, will women push Kamala Harris to victory in the US election. For this and more tune in to Daybreak Africa!

This week's conversation focuses on the current spread of M-Pox (formerly Monkeypox) in Africa and the response to the outbreak. Dr. Boghuma Titanji, an infectious disease expert at Emory University, discusses the history of M-Pox outbreaks in Africa and the factors contributing to its spread. The conversation also explores the role of African governments, the Africa CDC, and the international community in addressing the outbreak. The need for increased investment in healthcare, research, and development in Africa is highlighted, as well as the importance of holding governments accountable and promoting grassroots education on healthcare funding. The conversation explores the challenges and potential solutions for Africa to produce its own vaccines and medications, emphasizing the untapped potential of the continent. It highlights the low percentage of vaccines and basic drugs manufactured in Africa and the competition with established manufacturing hubs in other countries. Trust in locally produced vaccines is also discussed, with the need to shift the mindset of consumers. The conversation emphasizes addressing infrastructure and resource limitations before focusing on vaccine production. Considering the different transmission patterns and populations affected, the need for a tailored vaccination approach for M-POX outbreaks is highlighted. Exciting developments in infectious disease research and vaccine trials in Africa are also mentioned.00:00 The Current Spread of M-pox in Africa14:20 The Response to the M-pox Outbreak19:00 Underlying Issues: Lack of Investment and Prioritization23:21 The Role of Global Solidarity in Public Health25:45 Accountability and Self-Reliance in Healthcare29:35 Accountability and Local Ownership37:47 The Role of the Private Sector in Vaccine Production50:26 Tailoring Vaccination Strategies55:20 Promising Developments in Infectious Disease ResearchFollow Boghuma Titanji on LinkedInTo support us, consider becoming a paid subscriber on Patreon or making a one-time donation via PayPal.Follow us on X (@unfiltered_gh), LinkedIn, Instagram, and TikTok.

A fall in Chinese producer prices has fuelled concerns grow that deflation may be taking hold in the world's second-largest economy. Industrial producer prices fell 1.8 per cent in August, the most in four months. Steel and agriculture were among the sectors hit. Meanwhile, consumer prices rose 0.6 per cent.In Africa, the Africa CDC and WHO have launched a $600 million plan to combat mpox in 14 countries from September 2024 to February 2025. The initiative focuses on improving surveillance, laboratory detection, case management, infection prevention, and vaccination efforts to strengthen public health responses across the continent.Apple's iPhone 16 series, made in India, will be globally available shortly after its sales launch, marking a milestone for India's manufacturing sector and the Make-in-India initiative.

The mpox case surge in Africa has been declared a Public Health Emergency of International Concern (PHEIC) by the WHO. A new clade of the virus has emerged since the 2022 outbreak which has led to a rapid increase in cases. Professor Salim Abdool Karim, who is the the chair of the Africa CDC's Emergency Consultative Group and the director of CAPRISA, the Center for the AIDS Programme of Research in South Africa, joins Gavin Cleaver and Maneet Virdi to lay out in clear terms what's happening in Africa, what the PHEIC means, and what the future could look like.Send us your feedback!Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Quinze jours après que l'OMS a déclenché son plus haut degré d'alerte face à la résurgence des cas de Mpox en Afrique, l'épidémie continue de progresser sur le continent. La RDC reste de loin le pays le plus touché, mais l'épidémie s'étend. Treize autres pays présentent désormais des cas suspects. Plusieurs États ont promis d'envoyer prochainement des doses de vaccins. Quand ces doses seront-elles livrées ? En quelles quantités ? À quand la fabrication de vaccins sur le continent ? Entretien avec Jean Kaseya, le directeur général d'Africa CDC, le Centre de contrôle et de prévention des maladies de l'Union africaine. RFI : le Mpox poursuit sa progression sur le continent. L'Africa CDC fait état de près de 23 000 cas suspects détectés au 27 août et plus de 600 décès. Est-ce que ces chiffres vous inquiètent ?Jean Kaseya : Ces chiffres m'inquiètent au plus haut point, puisque ça prouve ce que nous disons tous les jours, que nous avons plusieurs épidémies Mpox en une. Pourquoi nous le disons, c'est puisque nous avons quatre variants qui se côtoient aujourd'hui en Afrique et qui ont des épidémiologies différentes, qui ont des symptomatologies qui se présentent dans les différents groupes d'âges et qui aujourd'hui n'ont pas suffisamment de recul en termes de médicaments et en termes de mesures applicables comme les vaccins et autres. Donc, ça m'inquiète au plus haut point.La RDC reste, et de loin, le pays le plus touché. Est-ce que c'est là où la progression est la plus forte ces derniers jours ?La progression est forte dans plusieurs provinces de la RDC. Mais la progression, on la voit aussi dans d'autres pays africains comme le Burundi, comme la RCA. Mais je dois dire, ce qui m'inquiète le plus, c'est que nous avons des pays qui sont non endémiques, mais qui ont rapporté pour la première fois des cas de Mpox comme le Gabon. Le ministre de la Sierra Leone m'informait aujourd'hui [mercredi 28 août], qu'il a eu un cas qui lui semble patent pour Mpox. Mais comme la Sierra Leone n'a pas de laboratoire fiable, il ne peut pas confirmer cela. Et donc moi, je considère, sur base de la symptomatologie, sur base de l'histoire de la maladie, que c'est un cas suspect de Mpox. Et je classe la Sierra Leone maintenant comme un nouveau pays qui est le 14e pays affecté par le Mpox.Plusieurs pays ont promis d'envoyer des doses de vaccin au continent. Quelle sera l'ampleur de ces livraisons ?Je voudrais reconnaître l'effort que les partenaires d'Afrique ont fait pour jusque-là, sécuriser les vaccins que nous avons. Nous avons d'abord, avec la branche humanitaire de l'Union européenne, sécurisé 215 000 doses. À cela s'ajoute les 100 000 doses que la France vient de donner par le même mécanisme de l'Union européenne et Africa CDC. En plus, nous avons 100 000 doses qui viendront de l'Allemagne. Mais je dois saluer le gouvernement espagnol, puisque l'Espagne donne 500 000 doses de vaccins. À ces doses-là qui représentent à peu près 1 million de doses, nous savons que Gavi est aussi en train de travailler avec nous, pour disponibiliser autour de 500 000 doses. Donc, nous pouvons dire qu'à ce stade, nous partons déjà autour de 1,5 ou 1,6 million de doses, sur les 10 millions que nous voulons avoir.À quelle échéance ces doses seront-elles livrées au continent ?Les vaccins que nous avons déjà eus, par exemple les 215 000 doses sont disponibles même à partir de demain. Ce que nous voulons, avant que les vaccins arrivent aux pays, c'est qu'il y ait une bonne logistique qui soit en place. Donc, je suis en train d'espérer et de travailler, comme je pense que le niveau de préparation des pays est assez optimal, que la semaine prochaine, les premières doses des vaccins sécurisés par Africa CDC, dans le mécanisme que nous avons mis en place, vont atterrir dans les différents pays.Mais combien de doses, précisément, pourraient arriver dès la semaine prochaine ?Nous allons commencer graduellement, et ça, c'est important que la population africaine le sache : nous avons décidé, à Africa CDC, de faire en sorte que ce qui s'est passé avec le Covid n'arrive plus. Donc, l'accord que nous avons avec la société Bavarian Nordic qui produit ces vaccins, c'est que cette année, ils vont nous donner 3 millions de doses. Mais ils vont aussi faire le transfert des technologies pour que ce vaccin soit produit sur le continent africain, par les compagnies africaines. Nous avons déjà un accord et nous avons déjà sélectionné la société qui pourrait faire cette production. Nous pensons que d'ici février, la société africaine qui a été sélectionnée sera en mesure d'inonder le marché africain avec le vaccin Mpox.À lire aussiMpox: pourquoi l'accès aux vaccins est problématique en Afrique?

Plus de 18.000 cas suspectés ou confirmés répertoriés depuis le début de l'année en Afrique selon l'agence de santé de l'Union africaine (Africa CDC)... le Monkeypox continue de se propager et on en parle dans ce magazine.

This week the Africa Centres for Disease Control and Prevention and the World Health Organization both declared mpox as a public health emergency. This is the first time the Africa CDC declared a public health emergency as it aims to increase its autonomy. There have been more than 17,000 suspected cases across the African continent, more than the total number of cases reported in 2023. In the United Kingdom, the International Rescue Committee is set to shed 1 in 9 staff as it faces a funding crisis. We explore the wider issue of reduced funding in global development despite rising humanitarian needs. To discuss these stories, and others, Devex President and Editor-in-Chief Raj Kumar sits down with Managing Editor Anna Gawel and Business Editor David Ainsworth for the latest episode of the podcast series. Sign up to the Devex Newswire and our other newsletters: https://www.devex.com/account/newsletters

Hatalmas óceánt találtak a Mars felszíne alatt, ami akár a földön kívüli életet is rejtheti Rakéta     2024-08-15 06:09:09     Tudomány Mars A legfrissebb adatok alapján könnyen elképzelhető, hogy a víz egyáltalán nem párolgott el a Marsról, ahogy a tudósok eddig gondolták, hanem lesüllyedt a bolygó mélyére. 5 aranyszabály a telefonos csalók kiszűrésére ICT Global     2024-08-15 08:37:38     Infotech Telefon Elszaporodtak a banki ügyfelek jóhiszeműségét kihasználó csalások. Az e-mailben történő adathalász támadások mellett egyre gyakoribbak a csaló telefonhívások. Ezek közös jellemzője, hogy pszichológiai nyomásgyakorlással próbálják az áldozatokat rábírni arra, hogy kiadják banki adataikat, amelyek birtokában aztán szabaddá válik az út a pénzükhöz is. Teljesen megújul a SimplePay online fizetőfelülete Digital Hungary     2024-08-15 10:24:04     Infotech Letisztultabb és modernebb kinézetet kap a SimplePay online fizetési felülete. Az újítást több lépcsőben, augusztus végétől teszik elérhetővé a felhasználóknak. Két életkorban kiugróan gyorsan öregszünk 24.hu     2024-08-15 12:25:54     Tudomány Egy friss kutatás szerint az öregedés nem feltétlen lineáris, és van két pont, amikor gyorsabban öregszünk. A majomhimlő újra terjed, csak most magasabb a halálozási rátája PlanetZ     2024-08-15 08:00:44     Tudomány Afrika Védőoltás WHO Kongó Az Mpox, más néven majomhimlő, globális vészhelyzethez vezetett. Az eseteinek és haláleseteinek száma riasztó mértékben megugrott Afrikában, különösen Kongóban. A WHO globális vészhelyzetet hirdetett, míg az Africa CDC nemzetközi segítséget kér a terjedés megfékezésére. Az új, halálosabb törzs és az oltóanyaghiány miatt a helyzet egyre súlyosabb, k Továbbra sem tudni, mikor térnek vissza a Boeing Starliner űrhajósai a Földre 444.hu     2024-08-15 07:10:52     Tudomány Boeing A két űrhajós júniusban indult az ISS-re, ahol egy hetet kellett volna eltölteniük, de azóta is ott vannak. Van, amikor villámgyorsan tud állást foglalni a NAIH Mínuszos     2024-08-15 07:33:54     Infotech NAIH A NAIH szerint a pácienseket, hozzátartozóikat és az egészségügyben dolgozókat ábrázoló felvételek személyes adatnak minősülnek. A kiszolgáltatott helyzetben lévő pácienseket, hozzátartozóikat, vagy akár az ott egészségügyi ellátást és más munkát végző személyeket is megilleti a személyes adatok védelméhez fűződő alapjog, az őket ábrázoló felvétele Szárnyal a kínai Tencent ITBusiness     2024-08-15 09:19:39     Cégvilág Infotech Kína Reklám Miután két negyedéven keresztül csökkentek a bevételek, a Tencent most jelentős nyereségnövekedésről számolhatott be, köszönhetően a reklámpiac folyamatos lendületének és a hazai játékrészlegnek, írja a Wall Street Journal. A Tencent nettó profitja 82%-kal nőtt az előző évhez képest, 47,63 milliárd jüanra (6,66 milliárd dollárra), ami meghaladta az Zavar az erőben: a fogyasztók nincsenek oda az MI-t forszírozó reklámokért Bitport     2024-08-15 10:31:00     Infotech Reklám Úgy tűnik, hogy a sikeres üzenetek az emberi kreativitás támogatását, nem pedig a felszámolását mutatják be, de a hirdetők még ezt a lécet is gyakran leverik. Kiemelkedően szerepeltek a magyar középiskolások az első MI diákolimpián Telex     2024-08-15 14:21:49     Tudomány Bulgária Középiskola A két csapat összesen három ezüstéremmel és egy összesített harmadik helyezéssel tért haza a Bulgáriában megrendezett versenyről. Az aknafedél, ami a legenda szerint kijutott az űrbe egy nukleáris robbanás során Rakéta     2024-08-15 08:09:08     Életmód Világűr A Szputnyikot is megelőzve az űrbe kijutó aknafedél legendája nem teljesen hamis, bár éppen a lényegi rész, a világűr meglátogatása valószínűleg túlzó állítás. Az azonban valószínű, hogy a fedél addig sosem látott sebességre gyorsult az Operation Plumbbob során. Szociális feladatokat ellátó robotflotta fejlesztésén dolgoznak az ELTE kutatói okosipar.hu     2024-08-15 05:03:07     Infotech Cégvilág Robot ELTE Az Eötvös Loránd Tudományegyetem (ELTE) kutatói egy nemzetközi együttműködésben szociális robotflotta fejlesztésén dolgoznak, céljuk olyan robotok tervezése és gyártása, amelyek például az idősgondozásban látnak el szociális és kiszolgáló funkciókat – közölte az ELTE az MTI-vel kedden. A várható élettartam megnövekedése, az egészségügyi szolgáltatá Lemoshatja a pályáról a többi gyártót a BYD új elektromos autója Infostart     2024-08-15 08:22:00     Külföld USA Kína Olcsó Elektromos autó Elon Musk Tesla BYD Fiat A méretében a Fiat Pandához hasonló Seagull háromszor olcsóbb az amerikai villanyautóknál, mégis ugyanazt a minőséget nyújtja. Elon Musk, a Tesla vezérigazgatója szerint a kínai elektromos autók már olyan színvonalat képviselnek, hogy kereskedelmi korlátozások alkalmazása nélkül is átvehetik a vezetést a világpiacon. A további adásainkat keresd a podcast.hirstart.hu oldalunkon.

Hatalmas óceánt találtak a Mars felszíne alatt, ami akár a földön kívüli életet is rejtheti Rakéta     2024-08-15 06:09:09     Tudomány Mars A legfrissebb adatok alapján könnyen elképzelhető, hogy a víz egyáltalán nem párolgott el a Marsról, ahogy a tudósok eddig gondolták, hanem lesüllyedt a bolygó mélyére. 5 aranyszabály a telefonos csalók kiszűrésére ICT Global     2024-08-15 08:37:38     Infotech Telefon Elszaporodtak a banki ügyfelek jóhiszeműségét kihasználó csalások. Az e-mailben történő adathalász támadások mellett egyre gyakoribbak a csaló telefonhívások. Ezek közös jellemzője, hogy pszichológiai nyomásgyakorlással próbálják az áldozatokat rábírni arra, hogy kiadják banki adataikat, amelyek birtokában aztán szabaddá válik az út a pénzükhöz is. Teljesen megújul a SimplePay online fizetőfelülete Digital Hungary     2024-08-15 10:24:04     Infotech Letisztultabb és modernebb kinézetet kap a SimplePay online fizetési felülete. Az újítást több lépcsőben, augusztus végétől teszik elérhetővé a felhasználóknak. Két életkorban kiugróan gyorsan öregszünk 24.hu     2024-08-15 12:25:54     Tudomány Egy friss kutatás szerint az öregedés nem feltétlen lineáris, és van két pont, amikor gyorsabban öregszünk. A majomhimlő újra terjed, csak most magasabb a halálozási rátája PlanetZ     2024-08-15 08:00:44     Tudomány Afrika Védőoltás WHO Kongó Az Mpox, más néven majomhimlő, globális vészhelyzethez vezetett. Az eseteinek és haláleseteinek száma riasztó mértékben megugrott Afrikában, különösen Kongóban. A WHO globális vészhelyzetet hirdetett, míg az Africa CDC nemzetközi segítséget kér a terjedés megfékezésére. Az új, halálosabb törzs és az oltóanyaghiány miatt a helyzet egyre súlyosabb, k Továbbra sem tudni, mikor térnek vissza a Boeing Starliner űrhajósai a Földre 444.hu     2024-08-15 07:10:52     Tudomány Boeing A két űrhajós júniusban indult az ISS-re, ahol egy hetet kellett volna eltölteniük, de azóta is ott vannak. Van, amikor villámgyorsan tud állást foglalni a NAIH Mínuszos     2024-08-15 07:33:54     Infotech NAIH A NAIH szerint a pácienseket, hozzátartozóikat és az egészségügyben dolgozókat ábrázoló felvételek személyes adatnak minősülnek. A kiszolgáltatott helyzetben lévő pácienseket, hozzátartozóikat, vagy akár az ott egészségügyi ellátást és más munkát végző személyeket is megilleti a személyes adatok védelméhez fűződő alapjog, az őket ábrázoló felvétele Szárnyal a kínai Tencent ITBusiness     2024-08-15 09:19:39     Cégvilág Infotech Kína Reklám Miután két negyedéven keresztül csökkentek a bevételek, a Tencent most jelentős nyereségnövekedésről számolhatott be, köszönhetően a reklámpiac folyamatos lendületének és a hazai játékrészlegnek, írja a Wall Street Journal. A Tencent nettó profitja 82%-kal nőtt az előző évhez képest, 47,63 milliárd jüanra (6,66 milliárd dollárra), ami meghaladta az Zavar az erőben: a fogyasztók nincsenek oda az MI-t forszírozó reklámokért Bitport     2024-08-15 10:31:00     Infotech Reklám Úgy tűnik, hogy a sikeres üzenetek az emberi kreativitás támogatását, nem pedig a felszámolását mutatják be, de a hirdetők még ezt a lécet is gyakran leverik. Kiemelkedően szerepeltek a magyar középiskolások az első MI diákolimpián Telex     2024-08-15 14:21:49     Tudomány Bulgária Középiskola A két csapat összesen három ezüstéremmel és egy összesített harmadik helyezéssel tért haza a Bulgáriában megrendezett versenyről. Az aknafedél, ami a legenda szerint kijutott az űrbe egy nukleáris robbanás során Rakéta     2024-08-15 08:09:08     Életmód Világűr A Szputnyikot is megelőzve az űrbe kijutó aknafedél legendája nem teljesen hamis, bár éppen a lényegi rész, a világűr meglátogatása valószínűleg túlzó állítás. Az azonban valószínű, hogy a fedél addig sosem látott sebességre gyorsult az Operation Plumbbob során. Szociális feladatokat ellátó robotflotta fejlesztésén dolgoznak az ELTE kutatói okosipar.hu     2024-08-15 05:03:07     Infotech Cégvilág Robot ELTE Az Eötvös Loránd Tudományegyetem (ELTE) kutatói egy nemzetközi együttműködésben szociális robotflotta fejlesztésén dolgoznak, céljuk olyan robotok tervezése és gyártása, amelyek például az idősgondozásban látnak el szociális és kiszolgáló funkciókat – közölte az ELTE az MTI-vel kedden. A várható élettartam megnövekedése, az egészségügyi szolgáltatá Lemoshatja a pályáról a többi gyártót a BYD új elektromos autója Infostart     2024-08-15 08:22:00     Külföld USA Kína Olcsó Elektromos autó Elon Musk Tesla BYD Fiat A méretében a Fiat Pandához hasonló Seagull háromszor olcsóbb az amerikai villanyautóknál, mégis ugyanazt a minőséget nyújtja. Elon Musk, a Tesla vezérigazgatója szerint a kínai elektromos autók már olyan színvonalat képviselnek, hogy kereskedelmi korlátozások alkalmazása nélkül is átvehetik a vezetést a világpiacon. A további adásainkat keresd a podcast.hirstart.hu oldalunkon.

“It's a clarion call to action. It's a recognition that we can no longer afford to be reactive. We must be proactive and aggressive in our effort to eliminate this threat.” Africa's leading health body - Africa CDC – has declared the rapidly rising cases of Mpox in East Africa a public health emergency. Since the beginning of the year, nearly 14,000 cases and 450 deaths have been recorded in the Democratic Republic of Congo, the most affected country. And more cases are being recorded in other African countries - including a number, like Uganda and Kenya, which are seeing the disease for the first time. So what should the global response be to what's been called the ‘most dangerous' strain of the disease yet? Presenter: Alan KasujjaGuests: Dr Jean Claude Udahemuka of the University of Rwanda and Dr Matshidiso Moeti - WHO Regional Director for Africa.

Matangazo ya saa nzima kuhusu habari za kutwa, ikiwa ni pamoja ripoti kutoka kwa waandishi wetu sehemu mbali mbali duniani na kote Afrika Mashariki na Kati, na vile vile vipindi na makala maalum kuhusu afya, wanawake, jamii na maendeleo.

The European Parliamentary elections will take place next month, and with anti-aid and anti-migrant parties poised to make big gains, there are fears for the future of the world's second-largest development budget. According to one senior Brussels politician, the controversial swiping of €2 billion from the development pot to fund a crackdown on illegal migration could just be the start of the European Union's reduced focus on supporting global development initiatives. We explore how Europe's political landscape is changing, as well as what it could mean to the EU's approach to foreign assistance. In South Africa, we found that the country's politics is preventing NGOs from effectively delivering health services to refugees and migrants. Aid groups and civil society organizations are trying to untangle the snarled problem of how to guarantee access to health services for all people who are far from home — whether that home is in another country or somewhere else in South Africa — without creating disparities in health care services that enrage local communities. On the topic of the continent, Devex obtained a copy of an African Union audit that examined accusations against Africa Centres for Disease Control and Prevention's Director General Dr. Jean Kaseya. The audit, which was finalized in March, analyzed over a dozen allegations in a February whistleblower email. We dig into the claims, including allegations of misusing funds, flouting rules, and exhibiting favoritism, among others. For the latest episode of our podcast series, Devex President and Editor-in-Chief Raj Kumar sits down with Managing Editor Anna Gawel and Senior Reporter Sara Jerving to discuss these stories and others. Sign up to the Devex Newswire and our other newsletters: https://www.devex.com/account/newsletters

Host Javier Guzman launches Season 2 with reflections on global progress on preparedness since the pandemic, then speaks with H.E. Dr. Jean Kaseya of Africa CDC about how Africa CDC is translating lessons from COVID-19 into stronger, more resilient systems.

This week we published an article on how USAID spent its money last year. We noted that the agency spent $38.1 billion through its assistance and acquisition mechanism in the fiscal year that ended in September 2023. From the data it is evident that USAID has increased its spending for humanitarian crises, including the war in Ukraine. The Africa Centres for Disease Control and Prevention released their wishlist for the pandemic treaty. However, with countries in the global north — including the United Kingdom, Germany, and France — slashing their aid budgets, questions are being raised about whether there is an appetite for another pandemic financing mechanism, which is among one of the agency's asks. On the topic of the Africa CDC, its acting deputy director-general, Dr. Ahmed Ogwell Ouma, is resigning from the organization this month as he wasn't allowed to apply for the deputy director-general position due to country quotas. Dr. Raji Tajudeen will become the acting deputy director-general until a formal appointment is made. To dig into these stories and others, Devex President and Editor-in-Chief Raj Kumar sits down with Patrick Fine from Brookings and Devex Associate Editor Rumbi Chakamba for the latest episode of our weekly podcast series. Sign up to the Devex Newswire and our other newsletters: https://www.devex.com/account/newsletters

Southern Africa Development Community (SADC) health ministers have refused to accept a proposal by the Africa Center for Disease Control to declare cholera a public health emergency in SADC member countries. This, as cholera has affected nearly 15 member states, according to the Lusaka Times. Khumbize Kandodo Chiponda, Malawi's health minister, tells VOA's James Butty, the Africa CDC needs to develop guidelines because cholera's impact varies from country to country.

In this episode, we have the privilege of hosting Dr. Mosoka Fallah, a distinguished figure in the field of public health in Africa. Dr. Fallah has been a leading force in combatting infectious disease outbreaks across the continent. Notably, his remarkable efforts in mobilizing local communities in Liberia during the 2013-2015 Ebola outbreak earned him recognition as one of Time Magazine's Persons of the Year in 2014. Currently, Dr. Fallah serves as the program manager for Africa CDC's "Saving Lives and Livelihoods" initiative, a groundbreaking $1.5 billion partnership with the Mastercard Foundation. This initiative is dedicated to promoting vaccine equity in Africa by supporting vaccine distribution, manufacturing, and bolstering the region's public health infrastructure. During our conversation, Dr. Fallah provides insights into the progress of the "Saving Lives and Livelihoods" initiative to date, shedding light on the pivotal role that digital health and technology play in enabling the initiative to reach its ambitious objectives. For more information about the "Saving Lives and Livelihoods" initiative, please visit: https://africacdc.org/saving-lives-and-livelihoods/ MedxTek Africa is produced and hosted by Dr Sam Oti, and co-edited by Veronica Ojiambo. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

On this episode we are speaking with Georgios Theocharopoulos, Scientific Officer for Emergency Preparedness and Response, to discuss ECDC4AfricaCDC, a four-year capacity- and partnership-building project between ECDC and Africa CDC. You can find more information on the ECDC4AfricaCDC project here. For general information about ECDC, please visit ⁠⁠⁠⁠ecdc.europa.eu⁠⁠⁠⁠, or follow us on ⁠⁠⁠⁠social media⁠⁠⁠⁠.

Ambassador Dr. John N. Nkengasong, Ph.D. ( https://www.state.gov/biographies/john-n-nkengasong/ ), is U.S. Global AIDS Coordinator and Special Representative for Health Diplomacy, a position he was officially sworn in on June 13, 2022, where he leads, manages, and oversees the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). PEPFAR is the largest commitment by any nation to address a single disease in history, prevent millions of HIV infections, save lives, and make progress toward ending the HIV/AIDS pandemic. Born in Cameroon, Dr. Nkengasong is the first person of African origin to hold this position. In 2017, Dr. Nkengasong was appointed as the first Director of the Africa Centers for Disease Control and Prevention (Africa CDC) headquartered in Addis Ababa, Ethiopia. Through his leadership, a framework for moving Africa CDC into a full autonomous health agency of the Africa Union was established. Dr. Nkengasong led efforts to create policy frameworks to guide countries to establish and strengthen their public health institutes and defined and implemented a system to collate national surveillance data. He also led the COVID-19 response in Africa, coordinating with heads of state and governments across the continent, and among other achievements to fight the COVID-19 pandemic, he helped secure 400 million doses of COVID-19 vaccines at the height of vaccine scarcity. During his tenure, he was appointed as one of the World Health Organization's special envoys on COVID-19 preparedness and response. Dr. Nkengasong served as the U.S. Centers for Disease Control and Prevention (CDC) Division of Global HIV and Tuberculosis' International Laboratory Branch Chief and as the Associate Director for Laboratory Science. Subsequently, he served as Acting Deputy Director at the CDC Center for Global Health and Co-Chair of the PEPFAR's Laboratory Technical Working Group. As a leading virologist with over 30 years of experience in public health, Dr. Nkengasong was appointed as a board member for the International AIDS Vaccine Initiative in New York, and the Coalition for Epidemic Preparedness Innovation, in Norway. Dr. Nkengasong received his B.Sc. from the Faculty of Science, University of Yaoundé, Cameroon; his M.Sc. from the Institute of Tropical Medicine, Antwerp, Belgium; and his Ph.D. from the Faculty of Medicine, University of Brussels, Belgium. He also received a Diploma in Leadership and Management from the Kennedy School of Government at Harvard University. Dr. Nkengasong is the recipient of numerous prestigious awards and recognitions. Most recently, he served as one of the World Health Organization Director General's Special Envoys for COVID-19. In 2021, Dr. Nkengasong was recognized as Time Magazine's 100 Most Influential People, where he was described as “a modern-day hero.” Additional awards include the U.S. Secretary of Health and Human Services Award for excellence in Public Health Protection Research, the Shepard Award, the U.S. Director's Recognitions Award and the William Watson Medal of Excellence, the highest recognition awarded by CDC; which was awarded for outstanding contributions and leadership in advancing global laboratory services and programs to support the PEPFAR. Most recently, Dr. Nkengasong was invited to become a member of the National Academy of Medicine and he became the first-ever laureate of the Virchow Prize for Global Health, for his dedication to improving the health and wellbeing of the world's most vulnerable people. He has authored or co-authored over 250 peer-reviewed papers and book chapters in professional journals. Support the show

Welcome once again to the global health unfiltered podcast, a podcast about unspoken realities about global health in Africa and the world.  Today, we will be talking about funding global health initiatives; who funds what? How are the decisions made? Are African countries too reliant on external funding for public health? And we have an awesome guest with tons of experience in this sector who will be sharing his views with us. We would also like to acknowledge the sponsors of this episode, the “Promoting Decolonization using innovative knowledge practices" grant hosted by the Center for Tropical Medicine and Global Health of Oxford University's Nuffield Department of Medicine. Dr. Sam Oti is a Senior Program Specialist at Canada's International Development Research Centre (IDRC). He operates out of the Nairobi-based regional office for Eastern and Southern Africa, where he serves as the primary point of contact for IDRC's global health initiatives.  He is also a commissioner on the Chatham House Commission for Universal Health and a co-founder of the Network of Impact Evaluation Researchers in Africa. Additionally, Dr. Oti hosts “MedxTek Africa”; a popular podcast highlighting digital health and health technology innovations from across the African continent. In 2020, Dr. Oti co-founded the Global Health Decolonisation Movement in Africa – a professional network that is seeking to mobilize a critical mass of African voices to speak out about what we perceive as the manifestations of coloniality in global health. The movement's mission strongly aligns with the Africa CDC's call for a “New Public Health Order”.Resources:https://wellcomecollection.org/articles/Y1FlZxEAAEolDkdAhttps://www.oecd-ilibrary.org/development/development-co-operation-report-2023_2c087f8b-enhttps://academic.oup.com/isq/article/66/1/sqab092/6473249 Follow us on Twitter (@unfiltered_gh), LinkedIn (Global Health Unfiltered!), and Instagram (@ghunfiltered).Keep up with us on Twitter: @desmondtanko @ulricksidney and @DrellaamoakoContact us: unfilteredgh@gmail.comAudio Production and social media marketing: Diana NkhomaResearch intern: Chisomo MwaleTheme music: Antidote by KetsaArtwork: Chidiebere Ibe

Check me out on https://www.facebook.com/groups/10902... . Twitter.com Hardtalkradio Live in 4k https://gettr.com/user/hardtalkradio79 Instagram Hardtalk79 https://spotifyanchor-web.app.link/e/... https://cash.app/$HARDTRADIO Feel free to donate if you feel to do so and like the content. If you have any current event stories or videos that you want me to cover hit me up at Redpillman1988@gmail.com --- Support this podcast: https://podcasters.spotify.com/pod/show/red-pill-man/support

Dr. Ebere Okereke, MD is a highly respected public health physician, specializing in global health security and health system strengthening, who has dedicated her career and won awards for her work promoting women and under-represented groups in public health leadership. Dr. Okereke currently serves as a Senior Adviser in Health at the Tony Blair Institute for Global Change ( https://www.institute.global/experts/ebere-okereke ), honorary senior public health adviser at Africa CDC, Associate Fellow at Chatham House, and is the incoming CEO of Africa Public Health Foundation ( https://aphf.africa/ ). Dr. Okereke is currently on a career break from Public Health England (now the UK Health Security Agency) where she led the UK-aid funded International Health Regulations strengthening project; a technical assistance project aimed at sustainably strengthening public health systems. Dr. Okereke is an experienced trainer, coach and mentor and was an honorary senior lecturer at the Leeds and Hull-York medical schools. Dr. Okereke is a graduate of the University of Nigeria College of Medicine and a Fellow of the UK Faculty of Public Health. Her journey in global health started at the Liverpool School of Tropical Medicine (LSTM) where she was first introduced to the field of communicable diseases and where she completed post-graduate work in International Health Consultancy. After leaving LSTM for the first time, Dr. Okereke joined the Public Health Specialty Training Program, where she trained across Northern England and became a consultant in communicable disease control. Her interests then took her to emergency preparedness, emerging and re-emerging infections, and zoonoses, ultimately leading her to Kenya where she worked for the International Rescue Committee. Support the show

Dr. Daniel Christian KokoLinkedIn: https://www.linkedin.com/in/daniel-christian-koko-he-his-him-8b9b422a/ 

Jean-Philbert Nsengimana is Africa CDC's Chief Digital Advisor. He is also a former minister of ICT in Rwanda. In this episode, Phil shares Africa CDC's vision for digitally transforming Africa's public health systems. Among other things, we talk about Africa CDC's inaugural digital transformation strategy which will be launched on March 6, 2023 at the Africa Health Agenda International Conference (AHAIC 2023) in Kigali. For more information about AHAIC 2023, please visit: https://ahaic.org/ MedxTek Africa is produced and hosted by Dr Sam Oti, and co-edited by Veronica Ojiambo. If you have any thoughts on this episode, or recommendations of African health innovators that you'd like us to host on the show, please reach out directly by email: sam.oti@alumni.harvard.edu or find us on Twitter or LinkedIn. Please note that the MedxTek Africa Podcast is distinct from Dr. Oti's role as a Senior Program Specialist at Canada's International Development Research Centre. The information provided in this podcast is not medical advice, nor should it be construed or applied as a replacement for medical advice. The MedxTek Africa Podcast, its production team, guests and partners assume no liability for the application of the podcast's content.

Construction of the China-aided headquarters of the Economic Community of West African States (ECOWAS) is underway in Abuja, Nigeria. It's the latest in a long list of similar China-funded projects in different parts of the continent that include the almost complete Africa CDC headquarters in Ethiopia. To discuss further about the project, its significance and China's ties with Africa, host Zanele is joined by: His Excellency, Chinese Ambassador to Nigeria Cui Jianchun, and Lawal Sale, an Abuja-based Global Affairs analyst and China-Africa relations expert.

In this podcast, Dr. Eeks chats with Dr. Christopher Murray about his recent article published in The Lancet (2022) titled The Global Burden of Cancer Attributable to Risk Factors, 2010-2019, a Systematic Analysis for the Global Burden of Disease Study 2019. This is the largest effort to date to determine the gobal burden of cancer due to risk factors. He will discuss what the global burden of disease study is, how he and his team estimated the burden of cancer, the risk factors and the assessment framework used to link specific cancers to specific risks, what percentage of cancer is attributed to risk factors, what the greatest risks are, differences in high income vs low income countries and public health implications. Dr. Murray is Chair of Health Metrics Sciences at the University of Washington and Director of the Institute for Health Metrics and Evaluation (IHME). He also leads the Global Burden of Disease collaboration ( a systemic effort to quantify the comparitive magnitude of health loss due to diseases, injuries and risk factors.)He is both a physician and a health economist and his work has led to innovative methods for strengthening health measurements, analyzing the performance of health systems and producing forecasts for the future state of health. During the COVID-19 pandemic, the White House, European Commission, WHO EURO and Africa CDC have used IHME forecasts and policy scenarios as sources of evidence. You can contact Dr. Eeks at bloomingwellness.com.Follow Dr. Eeks on Instagram here.Or Facebook here.Or Twitter.Subcribe to her newsletter here!Support the show

Dr. Ahmed Ogwell ( https://africacdc.org/people/ahmed-ogwell-ouma/ ) is the Acting Director at the Africa Centers for Disease Control and Prevention (Africa CDC) – a specialized agency of the African Union (AU). In this capacity, he works with AU Member States and other partners, leading a team of experts in securing Africa's health through effective preparedness, early detection and rapid response to disease outbreaks and public health emergencies on the continent of Africa. Dr. Ogwell has over 25 years of experience in public health as a social and developmental agenda at national, regional, and global levels. He has ably held senior positions in national government, the United Nations (UN) system, non-governmental organizations, and the AU. Dr. Ogwell previously worked as an advisor to the World Health Organization Director General and worked at the World Health Organization Regional office for Africa. Originally from Kenya, Dr. Ogwell walked the first steps of his international leader's journey back home, founding both the Office for International Health Relations and the department for NCDs at the Ministry of Health of the Republic of Kenya. With a decade of civil service, he is well versed in supporting governments to achieve desirable public health outcomes, particularly in resource-constrained settings. Internationally, Dr. Ogwell is recognized for leading the negotiations for the Tobacco Control Treaty, contributing to the implementation of the WHO Framework Convention on Tobacco Control (WHO FCTC) particularly in the African continent. He was also one of the pioneers of the intergovernmental working group on Public Health, Innovation, and Intellectual Property in Africa. Dr. Ogwell is thus a pan Africanist at heart and a firm believer in the power of leveraging international experience to find local solutions tailored to local challenges. Dr. Ogwell is an alumnus of the University Of Nairobi School Of Public Health and the Center for International Health at the University of Bergen in Norway. 

Why Nigeria's federal prosecutor failed to convict Nnamdi Kanu? +++ Nigeria floods death toll passes 600 +++ Malawians criticize government's corruption fight +++ Uganda steps up fight against Ebola +++ Sports

African health ministers attending a high-level meeting following the Ebola outbreak in Uganda want two regional health bodies to set up an Africa Ebola coordination task force.They say this would oversee preparedness and response to the current outbreak as well as other epidemics in the continent.Acting director of the Africa Centres for Disease Control, Ahmed Ogwell, says Africa needs to stop seeking international assistance, as it is on its own during pandemics.The Africa CDC says the continent is dealing with 11 different public health outbreaks. They are monkeypox, cholera, flooding, influenza, Lassa fever, measles, yellow fever, hepatitis E, and the Crimean - Congo hemorrhagic fever.

The COVID-19 pandemic revealed stark inequalities in the global health architecture. As the virus spread, a handful of mostly wealthy countries proved to have the money, the private sector relationships, and the power to be first in line for vaccines, treatments and supplies — and global health institutions struggled to even the playing field. Health leaders on the African continent have taken that lesson to heart, and one institution at the forefront of a new vision for African health security is the Africa Centers for Disease Control. Raj Kumar, editor in chief of Devex, spoke to Dr. Ahmed Ogwell Ouma, second in command at Africa CDC, about how the continent's quest for greater self-reliance is unfolding — and what a more regional approach to preparing for pandemics might look like.

Infectious diseases like malaria, tuberculosis, and HIV remain major causes of death and disability in Africa accounting for about 1.2 million deaths every year in Africa. By 2050, it is estimated that up to 4 million deaths could occur on the continent due to emergent infectious pathogens and increasing antimicrobial resistance. The covid-19 pandemic has revealed uncomfortable realities about the state of public health institutions in Africa. This reality led Dr. John Nkengasong, the then Director of the Africa CDC to declare that “in order to secure its future and guarantee its development, Africa will need a new public health order to address infectious disease threats and the overall syndemic in the 21st century”. In this episode, we talk about this New Public Health Order for Africa with two global health experts who have written extensively on this topic, Dr. Ebere Okereke and Sheila Mburu from the Tony Blair Institute.We hope you enjoy this episode. Please subscribe and share with your friends and family. We apologize for the quality of the sound at certain parts of the interview. These were primarily due to poor internet connectivity. We will continue to work to improve the quality of our productions for your enjoyment.  Thank you!  Readings:Read Ebere and Sheila's articles A New Public-Health Order for Africa: What and why?A New Public-Health Order for Africa: Why Public-Health Institutions Are the Foundations of Strong Health SystemsFollow Ebere Okereke on Twitter: @DrEmereumJnrFollow Sheila Mburu on Twitter: @Mburu_HealthFollow us on Twitter (@unfiltered_gh) and Instagram (@ghunfiltered)Keep up with us on Twitter @desmondtanko  @ulricksidney and @DrellaamoakoContact us: unfilteredgh@gmail.comArtwork: Chidiebere IbeTheme music: Antidote by Ketsa

Africa's top public health agency says it had signed a memorandum of understanding with Pfizer for countries on the continent to receive supplies of the Paxlovid pill to treat COVID-19. The acting director of the Africa Centres for Disease Control and Prevention, Ahmed Ogwell Ouma, says the MOU would allow African countries to access Paxlovid at cost. The World Health Organization says that deaths in the continent from COVID-19 are expected to fall by nearly 94 per cent in 2022 compared with last year.

Professor Sarah Edwards and Professor Phyllis Illari discuss their contributions the STS's impact in philosophy of science and medicine. They were lead contributors to two top-rated “impact cases” in UCL's 2021 entry to the REF assessment, the UK's research excellence framework. That's a national review of university research productivity. Sarah's project involves policy-making about emerging diseases. Phyllis's project involves policy-making when evidence in conflicting and incomplete. Simply put, “impact” is a measure of how much a influence an academic university research project has had on non-academic communities, such as business, media, schools, and medicine.   Summary of Professor Edwards's project Edwards' research informed the World Health Organisation's (WHO) Ethics Guidance and a Training Manual for clinical research during epidemics of emerging and re-emerging infectious diseases, for which no effective treatments or vaccines are known. The ethics guidance applied to 4955 studies undertaken into WHO's priority infectious diseases and pathogens with over 88 million participants globally. Edwards' research has benefited individuals participating in clinical research by promoting wider access to new and repurposed medicines and by protecting the rights and interests of current patients. Edwards initiated the development of an Afrocentric ethics framework for clinical research during epidemics across Africa and supervised a project for the African Union Centres for Disease Control (Africa CDC), involving wide consultation, engagement, and training. Her expertise has been consulted over clinical research for COVID-19 by organisations such as WHO, Africa CDC, and the US FDA which issued new guidelines leading to >370 early approvals of medicines and medical products with surveillance for research.   Full impact case study https://results2021.ref.ac.uk/impact/999f7328-c0ea-441f-8808-bee2281a2c27?page=1   Summary of Professor Illari's project Public bodies, such as health boards or government departments, must reliably interpret evidence to properly inform their decision-making. Illari and Clarke's work explores the diverse types of evidence obtained from biological and social mechanisms and systems, and how these are used for multiple purposes. This has impacted on 1) international methodologies for evidence assessment in health by increasing the plurality of evidence they use, particularly evidence of mechanisms (NICE, IARC), and on 2) UK ethical frameworks for AI and data science by improving their evidence use, particularly their attention to anticipating and monitoring how systems including populations react to new ethics frameworks (Cabinet Office, DCMS, West Midlands Police, the NHS). The beneficiaries are patients who need high quality medical advice both in England and Wales and internationally, and all people in the UK affected by government and NHS data projects such as the UK Cabinet Office Framework for Data Ethics and the NHS Code of conduct for data-driven health and care technology.   Full impact case study https://results2021.ref.ac.uk/impact/716079e1-ae40-478d-a477-ba7ef89b5383?page=1   More about REF REF is a complex administrative process. For more about UCL's work across all REF categories: https://www.ucl.ac.uk/research/evaluation/research-excellence-framework/ref-2021 For more about REF from its organisers: https://www.ref.ac.uk/   Featuring   Interviewees   Professor Sarah Edwards UCL Professor of Bioethics https://iris.ucl.ac.uk/iris/browse/profile?upi=SJLED13   Professor Phyllis Illari UCL Professor of Philosophy of Science https://www.ucl.ac.uk/sts/illari   Interviewer   Professor Joe Cain UCL Professor of History and Philosophy of Biology https://ucl.ac.uk/sts/cain   Music credits   Intro and Exit music “Rollin At 5,” by Kevin MacLeod https://filmmusic.io/song/5000-rollin-at-5 License: http://creativecommons.org/licenses/by/4.0   Interval music “Silly intro,” by Alexander Nakarada https://filmmusic.io/song/4786-silly-intro License: http://creativecommons.org/licenses/by/4.0   Podcast information   “WeAreSTS” is a production of the Department of Science and Technology Studies (STS) at University College London (UCL). To find out more, and to leave feedback about the show, visit us online: https://www.ucl.ac.uk/sts/podcast STS Students and staff also can find on the website information about how to get involved with our programme. “WeAreSTS” producer is Professor Joe Cain. Twitter: @stsucl #WeAreSTS Editing and post-production by Professor Joe Cain.

Africa's top public health body has urged all those buying COVID-19 vaccines for the continent to place orders with South Africa's Aspen Pharmacare, saying the market was key to developing vaccine manufacturing on the continent. The Africa Centre for Disease Control and Prevention says it was doing everything it could behind the scenes to prevent a situation where Aspen closes its facility due to a lack of orders. A company executive says this was hailed as a game-changing moment for an under-vaccinated continent frustrated by sluggish Western handouts, but Aspen's COVID-19 vaccine plant now risks shutting down after receiving not a single order.

Pharmaceutical company Pfizer is set to supply Africa's top health body with its coronavirus pill. The drug - Paxlovid - is intended for use soon after symptoms develop in people at high risk of severe disease. Africa CDC director John Nkengasong says Paperwork for the deal between the Africa Centres for Disease Control and Pfizer is now in the hands of the African Union's legal office - after which a formal announcement will be made. He urged health ministries to adopt robust measures spanning vaccines and testing plus the treatments by Pfizer as well as Merck, whose molnupiravir coronavirus pill he said the Africa CDC was also seeking.

Dr. Nkengasong, Director of the Africa CDC and soon to be head of PEPFAR joined us for this 123rd episode, and the first episode of our Live From Munich mini-series, a collection of episodes recorded at the Munich Security Conference. He is a leader in the initiative to incorporate global health in security discussions like the Munich Security Conference. “We have seen how an outbreak of a disease can truly be a health security matter, and also human security, as well as even going as far as a national security threat.” The Covid-19 pandemic has shown us “the need for us to look at the security from a human perspective”, that “we are more connected as humanity”, and “the inequalities that we thought existed are more profound within countries between countries and between regions than we thought”. As North America and Europe begin this murky transition to the next stage of the pandemic, Dr. Nkengasong is concerned that we will “begin to refer to COVID as a disease that will soon be over in the US. And then of course, because of that, it becomes one of the neglected tropical diseases where we now have to rely on foundations or charity to take care of.” He recently called for a pause in vaccine donations: “we're saying that we have a lot of vaccines in the country. Now our problem is vaccination”. “I'm a big believer in that we should always pause to evaluate where we are in response, and then make corrective actions”. How will Africa overcome its major challenge of vaccine hesitancy? “I think every good public health practice as you and I know is local. The concepts are global, but in practice is local, which means Africa must take its own socio-cultural context and deal with it and then find the touchpoints” Dr. John Nkengasong is the Director of the Africa Centres for Disease Control and Prevention, and has been nominated by President Biden to be the next head of the Office of the Global AIDS Coordinator in charge of PEPFAR, the President's Emergency Plan for AIDS Relief.  

Dr. Nkengasong, Director of the Africa CDC and soon to be head of PEPFAR joined us for this 123rd episode, and the first episode of our Live From Munich mini-series, a collection of episodes recorded at the Munich Security Conference. He is a leader in the initiative to incorporate global health in security discussions like the Munich Security Conference. “We have seen how an outbreak of a disease can truly be a health security matter, and also human security, as well as even going as far as a national security threat.” The Covid-19 pandemic has shown us “the need for us to look at the security from a human perspective”, that “we are more connected as humanity”, and “the inequalities that we thought existed are more profound within countries between countries and between region than we thought”. As North America and Europe begin this murky transition to the next stage of the pandemic, Dr. Nkengasong is concerned that we will “begin to refer to COVID as a disease that will soon be over in the US. And then of course, because of that, it becomes one of the neglected tropical diseases where we now have to rely on foundations or charity to take care of.” He recently called for a pause in vaccine donations: “we're saying that we have a lot of vaccines in the country. Now our problem is vaccination”. “I'm a big believer in that we should always pause to evaluate where we are in respond, and then make corrective actions”. How will Africa overcome its major challenge of vaccine hesitancy? “I think every good public health practice as you and I know is local. The concepts are global, but in practice is local, which means Africa must take his own socio-cultural context and deal with it and then find the touch points”   Dr. John Nkengasong is the Director of the Africa Centers for Disease Control and Prevention, and has been nominated by President Biden to be the next head of the Office of the Global AIDS Coordinator in charge of PEPFAR, the President's Emergency Plan for AIDS Relief.  

This is Vaccine 411, the latest coronavirus vaccine information for February 23rd, 2022.Hong Kong is going to test its entire population of 7.5 million people three times for COVID in March. To get that done, testing capacity will be boosted to 1 million a day or more. The city's reported about 5,000 new infections since February 15 and the healthcare system is buckling. A lockdown of the entire city, something that's been done a few times in mainland China, is not currently being considered.Amidst criticism of vaccine inequities, donations of the vaccine to Africa were well-intentioned, but the Africa CDC has a message for the do-gooders. Stop it. They want all donations paused until the third or fourth quarter of this year. They say the problem isn't a supply shortage, it's logistics challenges combined with vaccine hesitancy. As a result, there's a lot of vaccine just going to waste. Lots of numbers are falling, like case rates, death rates, hospitalizations, COVID restrictions, etc., but there's something else that has absolutely plummeted in demand. PCR tests. The CDC says nationwide demand for a COVID-19 PCR test has dropped 63% since early January. You could attribute part of that to the government mailing out free rapid tests but, PCR tests are a different, and proposedly more accurate way to find out if you're infected or not.Cruise lines, one right after the other, have been dropping their mask mandates. Carnival, Royal Caribbean, Norwegian, and Virgin have either already stopped requiring masks in most indoor settings or will start next month. MSC Cruises and Disney have not made that decision yet. The new goal is making sure passengers are fully vaccinated and boosted.Throughout the pandemic, most of us have been amazed at what we didn't know. And even now in February of 2022, it's amazing what we still don't know. On that list of still unknowns is how many booster shots we'll need, how long immunity from vaccines lasts, are there more dangerous variants coming, why does COVID make some people seriously ill and give people long COVID while other people shrug it off, and where did COVID-19 come from? Science has no answers for these questions so you can continue to argue about them amongst yourselves. In the United States, cases were down 65%, deaths are down 19%, and hospitalizations are down 43% over 14 days. The 7-day average of new cases has been trending down since January 14. The five states that had the most daily deaths per 100,000 are Tennessee, Maine, Mississippi, West Virginia, and Oklahoma. There are 27,107,363 active cases in the United States.The top 10 areas with the highest number of recent cases per capita according to The New York Times: Nome Census Area, AK. Manassas Park, VA. Marengo, AL. Pointe Coupee, LA. Attala, MS. Big Horn, MT. Perry, KY. Glacier, MT. Elmore, ID. And Washington, TN.There have been 938,938 deaths in the U.S. recorded as COVID-related.The top 3 vaccinating states by percentage of population that's been fully vaccinated: Rhode Island at 80.3%, Vermont at 80%, and Maine at 78.2%. The bottom 3 vaccinating states are Alabama at 50%, Wyoming at 50.5%, and Mississippi at 50.7%. The percentage of the U.S. that's been fully vaccinated is 64.7%.Globally, cases were down 34% and deaths down 16% over 14 days, with the 7-day average trending down since January 25. There are 66,265,532 active cases around the world.The five countries with the most new cases: Germany 158,507. Russia 135,172. Brazil 101,285. South Korea 99,550. And France 97,382. There have been 5,904,723 deaths reported as Covid-related worldwide. See acast.com/privacy for privacy and opt-out information.

This is Covid 411, the latest on Omicron and other COVID variants, and new hotspots for February 23rd, 2022. Hong Kong is going to test its entire population of 7.5 million people three times for COVID in March. To get that done, testing capacity will be boosted to 1 million a day or more. The city's reported about 5,000 new infections since February 15 and the healthcare system is buckling. A lockdown of the entire city, something that's been done a few times in mainland China, is not currently being considered.Amidst criticism of vaccine inequities, donations of the vaccine to Africa were well-intentioned, but the Africa CDC has a message for the do-gooders. Stop it. They want all donations paused until the third or fourth quarter of this year. They say the problem isn't a supply shortage, it's logistics challenges combined with vaccine hesitancy. As a result, there's a lot of vaccine just going to waste. Lots of numbers are falling, like case rates, death rates, hospitalizations, COVID restrictions, etc., but there's something else that has absolutely plummeted in demand. PCR tests. The CDC says nationwide demand for a COVID-19 PCR test has dropped 63% since early January. You could attribute part of that to the government mailing out free rapid tests but, PCR tests are a different, and proposedly more accurate way to find out if you're infected or not.Cruise lines, one right after the other, have been dropping their mask mandates. Carnival, Royal Caribbean, Norwegian, and Virgin have either already stopped requiring masks in most indoor settings or will start next month. MSC Cruises and Disney have not made that decision yet. The new goal is making sure passengers are fully vaccinated and boosted.Throughout the pandemic, most of us have been amazed at what we didn't know. And even now in February of 2022, it's amazing what we still don't know. On that list of still unknowns is how many booster shots we'll need, how long immunity from vaccines lasts, are there more dangerous variants coming, why does COVID make some people seriously ill and give people long COVID while other people shrug it off, and where did COVID-19 come from? Science has no answers for these questions so you can continue to argue about them amongst yourselves. In the United States, cases were down 65%, deaths are down 19%, and hospitalizations are down 43% over 14 days. The 7-day average of new cases has been trending down since January 14. The five states that had the most daily deaths per 100,000 are Tennessee, Maine, Mississippi, West Virginia, and Oklahoma. There are 27,107,363 active cases in the United States.The top 10 areas with the highest number of recent cases per capita according to The New York Times: Nome Census Area, AK. Manassas Park, VA. Marengo, AL. Pointe Coupee, LA. Attala, MS. Big Horn, MT. Perry, KY. Glacier, MT. Elmore, ID. And Washington, TN.There have been 938,938 deaths in the U.S. recorded as COVID-related.The top 3 vaccinating states by percentage of population that's been fully vaccinated: Rhode Island at 80.3%, Vermont at 80%, and Maine at 78.2%. The bottom 3 vaccinating states are Alabama at 50%, Wyoming at 50.5%, and Mississippi at 50.7%. The percentage of the U.S. that's been fully vaccinated is 64.7%.Globally, cases were down 34% and deaths down 16% over 14 days, with the 7-day average trending down since January 25. There are 66,265,532 active cases around the world.The five countries with the most new cases: Germany 158,507. Russia 135,172. Brazil 101,285. South Korea 99,550. And France 97,382. There have been 5,904,723 deaths reported as Covid-related worldwide. See acast.com/privacy for privacy and opt-out information.

On this edition of Straight Talk Africa, host Haydé Adams brings you a special town hall program on the current state of affairs in the fight against COVID-19 and what is needed for African nations to respond, recover and rebuild. Guests include Mo Ibrahim, founder and chair of the Mo Ibrahim Foundation, Phionah Atuhebwe, vaccines introduction medical officer at WHO Africa, Dr. Ahmed Ogwell Ouma, deputy director of Africa CDC, Shabir Madhi, dean of the health sciences faculty at University of of Witwatersrand, Dr. Tsion Firew, assistant professor of Emergency Medicine at the Columbia University Medical Center and Aloysius Uche Ordu, director of Africa Growth Initiative at Brookings Institution.

On this edition of Straight Talk Africa, host Haydé Adams brings you a special town hall program on the current state of affairs in the fight against COVID-19 and what is needed for African nations to respond, recover and rebuild. Guests include Mo Ibrahim, founder and chair of the Mo Ibrahim Foundation, Phionah Atuhebwe, vaccines introduction medical officer at WHO Africa, Dr. Ahmed Ogwell Ouma, deputy director of Africa CDC, Shabir Madhi, dean of the health sciences faculty at University of of Witwatersrand, Dr. Tsion Firew, assistant professor of Emergency Medicine at the Columbia University Medical Center and Aloysius Uche Ordu, director of Africa Growth Initiative at Brookings Institution.

On this edition of Straight Talk Africa, host Haydé Adams brings you a special town hall program on the current state of affairs in the fight against COVID-19 and what is needed for African nations to respond, recover and rebuild. Guests include Mo Ibrahim, founder and chair of the Mo Ibrahim Foundation, Phionah Atuhebwe, vaccines introduction medical officer at WHO Africa, Dr. Ahmed Ogwell Ouma, deputy director of Africa CDC, Shabir Madhi, dean of the health sciences faculty at University of of Witwatersrand, Dr. Tsion Firew, assistant professor of Emergency Medicine at the Columbia University Medical Center and Aloysius Uche Ordu, director of Africa Growth Initiative at Brookings Institution.

The founding head of Africa CDC on how the world must prepare for the next variant; The forgotten U.S. corporate coup plot of 1934 and how it relates to the deadly January 6 insurrection; Juan González on "Takeover," the Oscar-shortlisted documentary about when the Young Lords took over a New York City hospital. Get Democracy Now! delivered right to your inbox. Sign up for the Daily Digest: democracynow.org/subscribe

The founding head of Africa CDC on how the world must prepare for the next variant; The forgotten U.S. corporate coup plot of 1934 and how it relates to the deadly January 6 insurrection; Juan González on "Takeover," the Oscar-shortlisted documentary about when the Young Lords took over a New York City hospital. Get Democracy Now! delivered right to your inbox. Sign up for the Daily Digest: democracynow.org/subscribe

The role of mass media in communicating the science of COVID-19, and in helping many of us understand our new reality cannot be underestimated. This is the time for media organizations to seize leadership perpetuated by social responsibility and public service journalism given the ever-changing news on the pandemic. In this episode, we're joined by Dr. Mercy Korir, a medical doctor and journalist at the Standard Media Group (Kenya). She talks about journalism's role as members of “the fourth estate” and shares her assessment on how Africa's media is fairing in its COVID-19 coverage. Listen below or find the podcast on your favorite listening platform.https://nairobiideas.buzzsprout.comFurther Reading Dr. Mercy Korir on Twitter: @DrMercyKorirArticles:Dr. Mercy Korir. Standard Media Column - NairobiDr. Mercy Korir. Doctors Unmasked PodcastVerenado Meemee. Kenyan doctor dispelling COVID-19 myths through journalism. September 8, 2020. Alliance for Science.COVID-19 in Africa:Press Release. African Vaccine Acquisition Trust delivers 108,000 doses of COVID-19 vaccine to Ethiopia. September 6, 2021 Africa CDC. Stellah Kwasi. COVID-19 vaccine supply: Africa's proactive stance needs global backing. September 22, 2021. Institute for Security Studies. 

Katerini Storeng is an associate professor at the Centre for Development and the Environment at the University of Oslo.  She directs the interdisciplinary Global Health Politics research group and is the Deputy Director of the Independent Panel on Global Governance for Health, an initiative to follow up the Lancet-University of Oslo Commission's agenda on the political determinants of health inequity. Dr. Storeng's research advances a critical, ethnographic perspective on the social and political dynamics shaping global health research and policy. She is particularly interested in how global public-private partnerships, scientific communities and civil society coalitions shape and challenge prevailing understandings and approaches to global public health.Resources:"The uncomfortable truth about Norway's pandemic leadership" (Sept. 2021)"The Smartphone Pandemic: How Big Tech and public health authorities partner in the digital response to Covid-19", Global Public Health (2021)"Africa CDC, IFRC, and USAU call for Equitable Vaccine Coverage in Africa" (Sept. 2021)"Biden to Push Global Plan toBattle Covid as National Gaps Widen" (New York Times, 22 Sept. 2021)"Risky business: COVAX and the financialization of global vaccine equity", Globalization and Health (Felix Stein, 2021)Twitter:Katerini StorengDan Banik In Pursuit of Development https://in-pursuit-of-development.simplecast.com/  

US President Joe Biden has nominated Dr John Nkengasong to lead a public health programme on combating HIV/Aids, known as the President's Emergency Plan for Aids Relief.Dr Nkengasong is currently the head of the Africa CDC - the agency leading the fight against the Covid-19 pandemic.The US government initiative has been without a leader since February last year. Its former leader Deborah Birx left to join the US coronavirus task force.Experts say that many people were not getting tested while others were not able to take their medicine due to the interruption of supplies.

US President Joe Biden has nominated Dr John Nkengasong to lead a public health programme on combating HIV/Aids, known as the President's Emergency Plan for Aids Relief.Dr Nkengasong is currently the head of the Africa CDC - the agency leading the fight against the Covid-19 pandemic.The US government initiative has been without a leader since February last year. Its former leader Deborah Birx left to join the US coronavirus task force.Experts say that many people were not getting tested while others were not able to take their medicine due to the interruption of supplies.

US President Joe Biden has nominated Dr John Nkengasong to lead a public health programme on combating HIV/Aids, known as the President's Emergency Plan for Aids Relief.Dr Nkengasong is currently the head of the Africa CDC - the agency leading the fight against the Covid-19 pandemic.The US government initiative has been without a leader since February last year. Its former leader Deborah Birx left to join the US coronavirus task force.Experts say that many people were not getting tested while others were not able to take their medicine due to the interruption of supplies.

Dr. Ebere Okereke from Africa CDC explains the lessons picked from the Covid-19 pandemic and why the 2001 Abuja declaration is important.Churchill Ogutu, Head of research at Genghis Capital expounds on the latest M-Pesa milestone. 

The Nigerian government has decided to move ahead with a second dose of the AstraZeneca COVID-19 vaccine for the nearly 2 million citizens who received the vaccine - despite advice from Africa CDC and World Health Organization, that vaccine-strapped African countries could also choose to administer just one vaccine to ensure accessibility to a larger population. --- Send in a voice message: https://anchor.fm/jay-fm-podcast/message

Researchers at the Africa Centers for Disease Control and Prevention (CDC) recently analyzed Africa's “second wave” of Covid-19 in The Lancet. How does the situation in Africa look in comparison to the situations elsewhere? How are the continent's various countries faring in their struggles with the coronavirus? Dr. Stephanie Salyer of the Africa CDC talks to RBI Director John Torpey about the trajectory of the virus since the start of the pandemic, efforts to produce vaccines within the countries of the African Union, and other unique challenges facing Africa in its battle against the coronavirus. You can find a transcript here: https://ralphbuncheinstitute.org/2021/05/17/africas-experience-with-covid-19-with-dr-stephanie-salyer/

Here's today's Big Hard Facts: According to the Africa CDC, Africa lags behind most other regions in COVID-19 vaccinations, with just less than 14 million doses having been administered on the continent of 1.3 billion. Let's talk COVID Vaccination in Nigeria #NigeriainfoHF

In this episode, Katherine E. Bliss and J. Stephen Morrison speak with Dr. John Nkengasong, Director of the Africa CDC. The African continent has not seen the high Covid-19 caseload many feared at the beginning of the pandemic. We hear some reasons for this, what the lessons from Africa's experience with HIV tell us about the steps needed to enable African countries to effectively control the pandemic, and how leadership from the continent is working with COVAX, pharmaceutical companies, and global partners to obtain the vaccines they need.   Dr. John Nkengasong currently serves as the first Director of the Africa Centres for Disease Control and Prevention (Africa CDC). He is a leading virologist with nearly 30 years of work experience in public health. He joined our other podcast, Coronavirus Crisis Update, in May last year.

Episode 33With new Ebola outbreaks in Guinea and the Democratic Republic of Congo, Africa Science Focus investigates whether the Ebola virus can be sexually transmitted.  It is understood that the women who were the first reported patients in both countries were married to survivors of previous Ebola outbreaks. Scientists say this possible transmission link needs careful attention, without further stigmatising survivors, who face ongoing health and social challenges.   We hear from the World Health Organization's Margaret Harris, founder of the Sierra Leone Association of Ebola Survivors Yusuf Kabba, and Merawi Aragaw from the Africa CDC. And, researcher Jia Kangbai tells us about his new study, which will investigate what role sex could play in transmission of the Ebola virus. Is there something you want to know about science in Africa? Send us your questions from anywhere in the world and we'll find an expert to answer them — text or voice message via WhatsApp to +254799042513.   Africa Science Focus, with Selly Amutabi. Do you have any comments, questions or feedback about our podcast episodes? Let us know at podcast@scidev.net

The Africa Centres for Disease Control and Prevention says the Oxford/AstraZeneca Vaccine is safe.But it's advising countries that have a significant circulation of the 501.V2 covid-19 variant discovered in South Africa to make preparations to roll out other jabs instead.However, this contradicts World Health Organization recommendations.The WHO says countries which are dealing with new variants SHOULD press ahead with the Oxford vaccine because it's likely to prevent severe disease, hospitalisations and deaths.The Africa CDC says South Africa's decision to pause its use of Oxford/AstraZeneca doses will not change the continent's plans to procure the vaccine as planned.It's due to secure at least 600 million vaccine doses - including Oxford/AstraZeneca's. SABC Coletta wanjohi reports from Addis Ababa ....

Eugene Richardson (@real_ironist) joins us to discuss how global public health continues to use colonial frameworks for understanding health and disease, including for COVID-19 and Ebola modeling, and the need for reparations for health equity. He discusses how desocialized statistics support an unjust status quo, and how better forms of knowing can lead towards a world of justice. Eugene Richardson MD PhD is an infectious disease physician and anthropologist who previously served as the clinical lead for Partners In Health's Ebola response in Kono District, Sierra Leone, and has worked with the WHO and Africa CDC coordinating infectious disease response. His research focuses on biosocial approaches to epidemic disease prevention, containment, and treatment in sub-Saharan Africa; as part of this effort, he is chair of the Lancet Commission on Reparations and Redistributive Justice. He recently released Epidemic Illusions: On the Coloniality of Global Public Health (MIT Press, 2020): bit.ly/3cdhB4h. His recommended resources: Schwab, Tim (2020). "Are Bill Gates's Billions Distorting Public Health Data?", The Nation: bit.ly/3pnPIu1 Mbembe, Achille (2008). "What is Postcolonial Thinking? An Interview with Achille Mbembe", Eurozine: bit.ly/39kqjvP Richardson, Eugene (2020). "Colonizer, Interrupted", Democratic Left: bit.ly/3iSPkBh Vannini, Phillip (2008). "Critical Pragmatism," in The SAGE Encyclopedia of Qualitative Research Methods, ed. Lisa M. Given: bit.ly/2NDX3Yx

Vanessa is an e-Patient Scholar at Stanford University Medicine X as well as antibiotic resistance and one health activist. She established Healthcare Communications and Social Media South Africa in 2013 which started as a Twitter chat to discuss sustainable health development. Vanessa also created the first CPD course in South Africa about e-Patients accredited by the South African Medical Association (SAMA) and has further provided training to various organisationsincluding the National Institute of Communicable Diseases (NICD) and the Africa CDC.

We bring you our fourth live Covid-19 Q&A, broadcast on Twitter and YouTube on 28 July with Professor Peter Piot, Director of LSHTM, Dr John Nkengasong, first Director of Africa CDC and presented by Sarah Boseley, Health Editor at The Guardian.

Weekly WHO update:  There are concerns about health workers on the continent. The WHO and the Africa CDC form a Covid-19 traditional remedy team. Patrice Lumumba's daughter demands her father's 'relics' from Belgium. See omnystudio.com/listener for privacy information.

Next Tuesday 28th July we are hosting our fourth COVID-19 Live Q&A with Peter Piot, Director of LSHTM, and John Nkengasong, Director of Africa CDC. Join our Q&A streamed on LSHTM's Twitter and YouTube channels to ask your questions direct to world-leading experts with moderation by Sarah Boseley, Health Editor at The Guardian.

In this edition of Straight Talk Africa guest host and VOA Health Correspondent Linord Moudou explores the impact Covid-19 is having on the continent. She is joined by Dr. Ahmed Ogwell Ouma Deputy Director of the Africa CDC, Dr. Quarraisha Abdool Karim Associate Scientific Director of CAPRISA (Center for the AIDS Program of Research in South Africa), Dr. Jeremie Zoungrana Country Director of Jhpiego in Burkina Faso and Aron Betru Managing Director of the Center for Financial Markets at the Milken Institute.  

The COVID-19 pandemic is having severe public health, economic and social impacts around the world, and Dr. John Nkengasong, Director of Africa Centres for Disease Control and Prevention (CDC) has called this public health emergency a “looming disaster” for the African continent. The Africa CDC has been at the forefront of limiting the health impact of the pandemic, coordinating efforts of member states, sourcing medical equipment globally and locally for countries on the continent, and providing guidelines on how countries can implement social distancing measures among other efforts. Delivering this mandate within the varying contexts of African countries is not without its challenges. Host Albert Zeufack, Chief Economist for the Africa Region at the World Bank, invites Dr. Nkengasong to tell us about the measures they are taking to fight the pandemic under these circumstances.

We are joined by Dr. Githinji Gitahi, CEO of Amref Health Africa, for a discussion on how to strengthen health systems in Africa, using Kenya as a national case study. We will look at how Amref works in partnership with the public, private, and social sector to increase sustainable health access to communities through solutions in human resources for health, health services delivery, and investments in health. With an eye to entrepreneurial and sustainable approaches, and amid the backdrop of a protracted COVID-19 crisis, a powerful economic and health impact case is to be made for investing in community health system strengthening.Amref Health Africa, is the leading health development international NGO in Africa, headquartered in Africa since 1957. It reaches more than 12 million beneficiaries annually over through 150 health projects in 35 countries of Africa.A passionate advocate for pro-poor Universal Health Coverage, Dr. Githinji Gitahi joined Amref Health Africa as the Global Chief Executive Officer in June 2015. Until his appointment to Amref Health Africa, Dr. Gitahi was the Vice President and Regional Director for Africa, Smile Train International. Prior to that, Dr. Gitahi was Managing Director for Monitor Publications in Uganda as well as General Manager for Marketing and Circulation in East Africa for the Nation Media Group. Dr. Gitahi is Co-Chair of the UHC2030 Steering Committee, a global World Bank and World Health Organization (WHO) initiative for Universal Health Coverage (UHC). He is a member of the Governing Board of the Africa Centres for Disease Control and prevention (Africa CDC), a specialized technical institution under the African Union. He serves as a member of the Africa Union's COVID19 Response Committee. He is a member of the Board of Directors of The Standard Group in Kenya, and was recently appointed as a member of the Board of Trustees of Safaricom Foundation.Dr. Gitahi Bachelor's Degree in Medicine from the University of Nairobi; a Master's degree in Business Administration, majoring in Marketing, from United States International University and has a Certificate for Strategic Perspectives for Nonprofit Management from Harvard University. In 2018, Dr. Githinji received a presidential commendation, ‘Moran of the Order of the Burning Spear' (MBS) in recognition of outstanding contribution to the health sector in his continuing work at the helm of Amref Health Africa.